Keywords: new, biotech, products, csl, plant, australia, set

New biotech products at CSL plant

Article | 27 September 1999

CSL of Australia is set to develop new biotechnology treatments forulcers and stomach cancer at its new A$14 million ($8.9 million) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in